SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0000885590-12-000070
Filing Date
2012-11-05
Accepted
2012-11-05 16:51:16
Documents
16
Period of Report
2012-09-30
Filing Date Changed
2012-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q valeantq32012.htm 10-Q 2623817
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 111058
3 EXHIBIT 10.4 exhibit104.htm EX-10.4 551420
4 EXHIBIT 10.5 exhibit105.htm EX-10.5 177777
5 EXHIBIT 10.6 exhibit106.htm EX-10.6 170310
6 EXHIBIT 10.8 exhibit108.htm EX-10.8 65244
7 EXHIBIT 31.1 exhibit311-q32012.htm EX-31.1 14686
8 EXHIBIT 31.2 exhibit312-q32012.htm EX-31.2 14640
9 EXHIBIT 32.1 exhibit321-q32012.htm EX-32.1 8568
10 EXHIBIT 32.2 exhibit322-q32012.htm EX-32.2 8550
  Complete submission text file 0000885590-12-000070.txt   25527627

Data Files

Seq Description Document Type Size
11 EXHIBIT-101.INS vrx-20120930.xml EX-101.INS 3884280
12 EXHIBIT-101.SCH vrx-20120930.xsd EX-101.SCH 214305
13 EXHIBIT-101.CAL vrx-20120930_cal.xml EX-101.CAL 119444
14 EXHIBIT-101.LAB vrx-20120930_lab.xml EX-101.LAB 3131547
15 EXHIBIT-101.PRE vrx-20120930_pre.xml EX-101.PRE 1588581
16 EXHIBIT-101.DEF vrx-20120930_def.xml EX-101.DEF 1268165
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 121180628
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1